Skip to main content

and
  1. No Access

    Article

    Phase I Study of Irinotecan/5-Fluorouracil/Leucovorin (FOLFIRI) with Sunitinib for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

    Sunitinib (S) is a multi-targeted tyrosine kinase inhibitor. It is synergistic with chemotherapy in preclinical models. We hypothesized that sunitinib in combination with fluorouracil, leucovorin, and irinotec...

    Sarbajit Mukherjee, Christos Fountzilas, Patrick M. Boland in Targeted Oncology (2020)